Debate erupts over new drug pricing policy

Published: 2006-07-24 06:57:00

Updated: 2006-07-24 06:57:00

It is fair that the Korean government should consider the new drug pricing issue under the current pharmaceutical circumstances, the nation's pharmaceutical group asserted on June 20.

The Korea Pharmaceutical Manufacturers Association (KPMA) said on July 20 that it had submitted its written op...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK